Delivery Order SPE2DB24D2100-SPE2DB25FBDKG

Award Date 4/9/25
Potential Completion Date 4/30/25
Potential Value $46K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of VYEPTI 100 mg/mL injectable medication. The contract has a firm fixed-price of $6,405.06 and an ultimate completion date of October 31, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through...
This contract award, valued at $5,785.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of VYEPTI 100 MG/ML vials, a prescription medication, with a completion date of January 28, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,337.55 firm fixed-price contract is for the supply of VYEPTI 100 MG/ML VIAL, a specialty pharmaceutical product. The order has an ultimate completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,287.20 firm fixed-price contract is for the supply of VYEPTI 100 MG/ML VIALML, a medication, with a performance period ending on February 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply VYEPTI 100 MG/ML VIAL medication. The contract has a ceiling value of $3,202.53 and a period of performance through August 22, 2024. It is a Firm Fixed Price, Delivery Order contract type with no set-aside designation. Amerisourcebergen is the prime contractor providing these pharmaceutical products to support military treatment...
This is a delivery order (SPE2DB22D3004|SPE2DB24FRZ48) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The $12,810.12 firm fixed-price contract has an ultimate completion date of October 21, 2024 and was awarded on September 27, 2024. This order is placed under an Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $5,337.55. The award covers the supply of 100 mg/mL vials of the medication VYEPTI, with a period of performance ending on November 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,943.08, is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 27, 2025. The contract was awarded on March 6, 2025 and does not have a set-aside designation, indicating open...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract (SPE2DX15D1053|SPE2DX24F6HYK) valued at $19,215.18 to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of VYEPTI 100 MG/ML VIALML pharmaceuticals. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,313.20 firm fixed-price delivery order is for the supply of VYEPTI 100 MG/ML VIAL medication. The contract has an ultimate completion date of December 13, 2024. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBDKG
    Delivery Order

This is a $46,287.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYEPTI 100 mg/ml vials, a specialty pharmaceutical product.

The contract is not designated under any set-aside program. It is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/9/25, 9:57 AM